Xu Cong Claire

EVP, Clinical Development at NBP

Sold, on record
$20k
Dollars the filings state
Form 4 sales
3
Latest Aug 31, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NBPNovaBridge BiosciencesEVP, Clinical Development

Sales by reason

0
Routine
0
Plan not stated
3
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NBPNo plan
    Jun 1, 2026 2026

    Sold 3,494 shares at $3.94 ($14k)

    Xu Cong Claire, SVP, Clinical Development

    No 10b5-1 planSold 1.2% of holdings ($1.2M position)290,154 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NBPNo plan
    Jul 6, 2026 +35 days

    Sold 4,485 shares at $0.89 ($4k)

    Xu Cong Claire, SVP, Clinical Development

    No 10b5-1 planSold 1.5% of holdings ($269k position)298,101 shares leftFiling

  3. 3 Form 4 sale NBPNo plan
    Aug 31, 2026 +56 days

    Sold 3,282 shares at $0.79 ($3k)

    Xu Cong Claire, EVP, Clinical Development

    No 10b5-1 planSold 1.1% of holdings ($243k position)304,201 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Xu Cong Claire
Source
Aug 31, 2026Sep 1, 2026NBPEVP, Clinical DevelopmentForm 4 sale3,282$3k1.1%No planSEC
Jul 6, 2026Jul 7, 2026NBPSVP, Clinical DevelopmentForm 4 sale4,485$4k1.5%No planSEC
Jun 1, 2026Jun 2, 2026NBPSVP, Clinical DevelopmentForm 4 sale3,494$14k1.2%No planSEC